Clinical Trial Update: Cognition in the Study of Tamoxifen and Raloxifene [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing cognition outcomes in aging with tamoxifen and raloxifene; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging
• Cognition Impairment

Drugs mentioned

• Raloxifene (raloxifene)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Wake Forest University | Conditions: Cognition, Aging | Phase 3 | Status: COMPLETED | Results posted: 2018-01-23